News | December 19, 2014

Two Guidelines Added to ACC Guideline Clinical App

App provides mobile access to guidelines, tools for treatment, prevention of heart disease

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and atrial fibrillation.

The ACC Guideline Clinical App was launched in November with the initial version including content based on guidelines for heart failure, cardiovascular risk assessment and treatment of blood cholesterol. In addition to the Executive Summary and Top 10 Points for each guideline, the app includes a collection of interactive tools such as dosing calculators, scoring tools and algorithms useful to clinicians in determining recommended care.

The ACC, which has been developing clinical practice guidelines in partnership with the American Heart Association for more than three decades, developed this app to serve as a mobile home for all ACC/AHA guideline content and related tools.

The ACC will continue to refine and expand the app. An additional update is expected in March with content and tools based on guidelines for the treatment of obesity and the management of lifestyle to reduce cardiovascular risk.

The American College of Cardiology Guideline Clinical App is available for free on iTunes and GooglePlay.

For more information: www.acc.org

 


Related Content

News | Heart Valve Technology

Aug. 4, 2025 — Corcym announced that its Perceval Plus sutureless aortic heart valve was used in a first-ever robotic ...

Home August 05, 2025
Home
News | Heart Valve Technology

July 10, 2025 — On July 2, 2025, Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination ...

Home July 11, 2025
Home
News | Heart Valve Technology

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling ...

Home June 27, 2025
Home
News | Heart Valve Technology

June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...

Home June 12, 2025
Home
News | Heart Valve Technology

May 27, 2025 — Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne ...

Home May 28, 2025
Home
News | Heart Valve Technology

May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the ...

Home May 02, 2025
Home
News | Heart Valve Technology

April 28, 2025 — The Society of Thoracic Surgeons (STS) has launched its latest surgical risk calculator designed for ...

Home April 29, 2025
Home
News | Heart Valve Technology

March 30, 2025 — Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data ...

Home March 31, 2025
Home
News | Heart Valve Technology

Feb. 22, 2025 — More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the ...

Home March 04, 2025
Home
News | Heart Valve Technology

Feb. 17, 2025 — The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive ...

Home February 18, 2025
Home
Subscribe Now